b*n
2 楼
想在sears 买个 nikon 24-70, 不知道靠不靠谱。不知哪位前辈有经验,给点意见。
c*o
3 楼
这种被政府调查的,结果未明很凶险。 类似的案例JNJ和AMGN都赔了至少几百M.
b*n
6 楼
多谢提醒, 果真不是sears. 是一个叫 cameta camera的,还是算了吧
x*n
9 楼
一笑而过。
j*9
11 楼
edu很快会跌。
b*n
14 楼
包子就是伪币吧,我查了下0.10可用,怎么发
T*C
22 楼
Orphan Label
"qualify for tax credits for certain clinical testing expenses and for a
seven-year exclusivity period during which the FDA is prohibited from
approving any other ACTH formulation for IS unless the other formulation is
demonstrated to be clinically superior to Acthar or is considered by the FDA
to have an active ingredient that is different from the active ingredient
of Acthar. "
【在 U********f 的大作中提到】![](/moin_static193/solenoid/img/up.png)
: label给的7年测试特权到期-- 这个英文怎么说?
: 我想GOOGLE 一下, 多谢了。
"qualify for tax credits for certain clinical testing expenses and for a
seven-year exclusivity period during which the FDA is prohibited from
approving any other ACTH formulation for IS unless the other formulation is
demonstrated to be clinically superior to Acthar or is considered by the FDA
to have an active ingredient that is different from the active ingredient
of Acthar. "
【在 U********f 的大作中提到】
![](/moin_static193/solenoid/img/up.png)
: label给的7年测试特权到期-- 这个英文怎么说?
: 我想GOOGLE 一下, 多谢了。
U*f
23 楼
you are right, I found this:
http://finance.yahoo.com/news/Questcor-Acthar-Drug-Getting-ibd-
it's been off-patent for decades
is
FDA
【在 T*C 的大作中提到】![](/moin_static193/solenoid/img/up.png)
: Orphan Label
: "qualify for tax credits for certain clinical testing expenses and for a
: seven-year exclusivity period during which the FDA is prohibited from
: approving any other ACTH formulation for IS unless the other formulation is
: demonstrated to be clinically superior to Acthar or is considered by the FDA
: to have an active ingredient that is different from the active ingredient
: of Acthar. "
http://finance.yahoo.com/news/Questcor-Acthar-Drug-Getting-ibd-
it's been off-patent for decades
is
FDA
【在 T*C 的大作中提到】
![](/moin_static193/solenoid/img/up.png)
: Orphan Label
: "qualify for tax credits for certain clinical testing expenses and for a
: seven-year exclusivity period during which the FDA is prohibited from
: approving any other ACTH formulation for IS unless the other formulation is
: demonstrated to be clinically superior to Acthar or is considered by the FDA
: to have an active ingredient that is different from the active ingredient
: of Acthar. "
n*c
24 楼
到现在还有人在pump QCOR. 真的是无语.下面这个是Citron的报告。 出报告的当天大
跌23%。
Questcor (NASDAQ:QCOR): A Single Digit Stock in 18 Months and Here's Why
http://www.citronresearch.com/2012/07/
跌23%。
Questcor (NASDAQ:QCOR): A Single Digit Stock in 18 Months and Here's Why
http://www.citronresearch.com/2012/07/
U*f
25 楼
NM 这不又是一个MUDDY WATER这类的空头机构,你把它当作神了?
它专门攻击中概股的,看看它对QIHU, 恒大地产
看看这个
http://www.citronresearch.com/citron-knows-china/
也攻击过EDU的,
EDU New Oriental Education 04/16/09 49.50 64.0000 29.29%
Formal SEC Investigation
它专门攻击中概股的,看看它对QIHU, 恒大地产
看看这个
http://www.citronresearch.com/citron-knows-china/
也攻击过EDU的,
EDU New Oriental Education 04/16/09 49.50 64.0000 29.29%
Formal SEC Investigation
U*f
26 楼
PUMP你个头,你作空只管作,SHORT 加PUT ,赚死你。
【在 n****c 的大作中提到】![](/moin_static193/solenoid/img/up.png)
: 到现在还有人在pump QCOR. 真的是无语.下面这个是Citron的报告。 出报告的当天大
: 跌23%。
: Questcor (NASDAQ:QCOR): A Single Digit Stock in 18 Months and Here's Why
: http://www.citronresearch.com/2012/07/
【在 n****c 的大作中提到】
![](/moin_static193/solenoid/img/up.png)
: 到现在还有人在pump QCOR. 真的是无语.下面这个是Citron的报告。 出报告的当天大
: 跌23%。
: Questcor (NASDAQ:QCOR): A Single Digit Stock in 18 Months and Here's Why
: http://www.citronresearch.com/2012/07/
T*C
27 楼
太幼稚了。今天已经回到19块了
【在 n****c 的大作中提到】![](/moin_static193/solenoid/img/up.png)
: 到现在还有人在pump QCOR. 真的是无语.下面这个是Citron的报告。 出报告的当天大
: 跌23%。
: Questcor (NASDAQ:QCOR): A Single Digit Stock in 18 Months and Here's Why
: http://www.citronresearch.com/2012/07/
【在 n****c 的大作中提到】
![](/moin_static193/solenoid/img/up.png)
: 到现在还有人在pump QCOR. 真的是无语.下面这个是Citron的报告。 出报告的当天大
: 跌23%。
: Questcor (NASDAQ:QCOR): A Single Digit Stock in 18 Months and Here's Why
: http://www.citronresearch.com/2012/07/
U*f
29 楼
我已卖了CALL了,涨多少我都只能赚20%
U*f
32 楼
Take a look at this comment:
if you compare Aetna policy statement in 2008 and 9-12 (recently updated)
there is no change in aetna policy at all. Yes, they might make it more
difficult to approve prior auth. but they are no denying acthar therapy
after steroid therapy fails. The updated policy on 9-14-12 states " This CPB
is revised to state that repository corticotropin is considered not
medically necessary for corticosteroid-responsive conditions because it has
not been proven to be more effective than corticosteroids for these
indications". Now, the keyword here is "corticosteroid-respon... conditions"
which implies acthar gel will not be reimbursed for patients who are
responsive to steroid therapy. However, no where it says it will not
reimburse for patients who failed steroid therapy. This is the language used
by citron and other short sellers and manipulated in their favor and
attacked the company by creating a fear and panic in the minds of investors
that other insurance companies will follow what Aetna did and qcor will lose
majority of its revenues. Coming back to the lawsuit, personally, I think
it will do no harm to the company since they are promoting their drug for
the indications that are fda approved. This is good buying opportunity at
this current level.
POINT: CITRON manipulated the wording to attack QCOR.
Tomorrow will be a good day!
【在 T*C 的大作中提到】![](/moin_static193/solenoid/img/up.png)
: It's still good entry point now. Will see 30 soon
if you compare Aetna policy statement in 2008 and 9-12 (recently updated)
there is no change in aetna policy at all. Yes, they might make it more
difficult to approve prior auth. but they are no denying acthar therapy
after steroid therapy fails. The updated policy on 9-14-12 states " This CPB
is revised to state that repository corticotropin is considered not
medically necessary for corticosteroid-responsive conditions because it has
not been proven to be more effective than corticosteroids for these
indications". Now, the keyword here is "corticosteroid-respon... conditions"
which implies acthar gel will not be reimbursed for patients who are
responsive to steroid therapy. However, no where it says it will not
reimburse for patients who failed steroid therapy. This is the language used
by citron and other short sellers and manipulated in their favor and
attacked the company by creating a fear and panic in the minds of investors
that other insurance companies will follow what Aetna did and qcor will lose
majority of its revenues. Coming back to the lawsuit, personally, I think
it will do no harm to the company since they are promoting their drug for
the indications that are fda approved. This is good buying opportunity at
this current level.
POINT: CITRON manipulated the wording to attack QCOR.
Tomorrow will be a good day!
【在 T*C 的大作中提到】
![](/moin_static193/solenoid/img/up.png)
: It's still good entry point now. Will see 30 soon
相关阅读
背着长枪短炮去看世博的朋友,毕神医的脚钉收到了被Ritz耍了。ebay上从加拿大买镜头要另外交关税么奥林巴斯发布两款长焦镜头nflx 攀龙附凤全幅是不是都是虚的?闪灯速度多快可以保证模特不眨眼?local有套2000的5d2+24105eBay 脑残,搞个 ”New Other“ Condition山寨 iPhone 4 $80,做得还真不错contax 80mm/2 270626303407 good deal?怀念K10Dwindows mail把我学校邮箱的信都下载并删除了,咋恢复呢国内现在福利这么好了?iPhone有没有自动连续拍照的软件?samsung 58" plasma $1250ZF/ZE 35/1.4 真的出来了今日deal速递t2i 大家都配得什么镜头